Error loading player: No playable sources found

FriCU11

New Systemic Treatment Options for Hepatobiliary Cancers

Date
March 19, 2021

Learning Objectives

  • Compare and contrast the differences between systemic therapy options available for first-line treatment of hepatobiliary cancers.
  • Describe how molecular profiling can help better inform clinical decision-making.
  • Identify the different options available for the treatment of hepatobiliary cancers based on the genetic abnormality detected.

Speaker

Speaker Image for Robin Kate Kelley
UCSF Helen Diller Family Comprehensive Cancer Center